By Counterforce Health Team in HyperHEP (hepatitis B immune globulin) —

How to Get HyperHEP Covered by Cigna in Florida: Prior Authorization Guide and Appeal Strategies

Quick Answer: Cigna requires prior authorization for HyperHEP (hepatitis B immune globulin) in Florida. To get approved, your doctor must submit documentation showing exposure to hepatitis B, your immunity status, and timing within CDC guidelines (ideally within 24 hours, up to 7 days). If denied, you have 180 days to appeal internally, then 4 months for external review. First step: Have your provider check your formulary tier at myCigna.com and submit PA with complete exposure documentation.

Table of Contents

  1. Cigna's HyperHEP Coverage Policy Overview
  2. Medical Necessity Requirements
  3. Step Therapy and Exceptions
  4. Quantity and Frequency Limits
  5. Required Diagnostics and Documentation
  6. Specialty Pharmacy Requirements
  7. Evidence to Support Medical Necessity
  8. Appeals Process for Florida Residents
  9. Common Denial Reasons and Solutions
  10. FAQ: HyperHEP Coverage in Florida

Cigna's HyperHEP Coverage Policy Overview

Cigna classifies HyperHEP (hepatitis B immune globulin) as a specialty medication requiring prior authorization across all plan types in Florida—HMO, PPO, and Medicare Advantage plans. The drug appears on Cigna's specialty tier formulary, meaning it's covered but requires medical review before approval.

Key Policy Points:

  • Prior authorization required for all HyperHEP prescriptions
  • Coverage follows CDC post-exposure prophylaxis guidelines
  • No routine step therapy for CDC-defined exposures
  • Specialty pharmacy dispensing typically required (Accredo)
  • Appeals process available for denials

You can find your specific formulary status by logging into myCigna.com or checking your plan's drug list PDF.

Medical Necessity Requirements

Cigna approves HyperHEP when medical necessity is clearly documented according to CDC guidelines. Here's what your doctor needs to prove:

Primary Indications Covered:

  • Post-exposure prophylaxis: After needlestick, sexual contact, or other blood/body fluid exposure
  • Perinatal prevention: For infants born to HBsAg-positive mothers
  • Transplant protocols: Prevention of hepatitis B recurrence (specific to liver transplant)

Required Clinical Documentation:

  • Exposure details: Type, timing, and source patient's HBsAg status
  • Patient immunity status: Vaccination history and anti-HBs levels if available
  • Timing justification: Administration within CDC-recommended windows
  • Weight-based dosing: 0.06 mL/kg for adults; 0.5 mL for newborns
Tip: Emergency departments can often administer HyperHEP immediately while obtaining retroactive prior authorization for urgent exposures.

Step Therapy and Exceptions

Unlike many specialty medications, HyperHEP typically doesn't require step therapy for CDC-defined post-exposure scenarios. However, Cigna may require documentation that:

  • Active hepatitis B vaccination alone is insufficient (due to timing)
  • The patient is non-immune or immunity status is unknown
  • Combination therapy (HBIG + vaccine) is medically appropriate

Exception Pathways: If step therapy is incorrectly applied, your provider can request an exception by demonstrating the urgency of post-exposure prophylaxis.

Quantity and Frequency Limits

Cigna's quantity limits align with FDA-approved dosing:

Indication Dose Frequency Typical Approval
Post-exposure (adult) 0.06 mL/kg IM Single dose One-time approval
Perinatal 0.5 mL IM Within 12 hours of birth One-time approval
Transplant prophylaxis Variable IV dosing Multiple doses over months Requires detailed protocol

For transplant patients requiring ongoing doses, Cigna may approve multiple vials with anti-HBs monitoring requirements and target titer documentation.

Required Diagnostics and Documentation

Your healthcare provider should include these elements in the prior authorization request:

Essential Lab Work:

  • Source patient's HBsAg status (positive or unknown high-risk)
  • Recipient's anti-HBs level (if available)
  • Patient weight for dosing calculations

Clinical Documentation:

  • Incident report for occupational exposures
  • Timeline from exposure to treatment request
  • Contraindications to hepatitis B vaccine (if applicable)
  • ICD-10 codes: Z87.19 (personal history of hepatitis B) or Z20.5 (contact with hepatitis B)
Note: Documentation must clearly establish the exposure occurred within the effective treatment window per CDC guidelines.

Specialty Pharmacy Requirements

Cigna typically requires HyperHEP to be dispensed through their designated specialty pharmacy, Accredo. However, urgent post-exposure cases may be exceptions.

Standard Process:

  • Provider submits PA through Cigna's portal
  • If approved, prescription routes to Accredo
  • Product ships to administering facility
  • Administration must occur at medical facility (not home)

Emergency Situations: Hospital pharmacies can often stock and administer immediately, with prior authorization obtained retroactively within 72 hours.

Evidence to Support Medical Necessity

When appealing denials or submitting initial requests, reference these authoritative sources:

  • CDC MMWR Guidelines: Post-exposure prophylaxis recommendations
  • FDA Product Labeling: Official HyperHEP prescribing information
  • ACIP Recommendations: Hepatitis B prevention guidelines
  • Medical Literature: Peer-reviewed studies on HBIG effectiveness

Your provider's medical necessity letter should cite specific CDC timing windows and demonstrate how your case fits established protocols.

Appeals Process for Florida Residents

If Cigna denies your HyperHEP request, Florida law provides robust appeal rights:

Internal Appeal (First Level)

  • Deadline: 180 days from denial notice
  • Process: Submit via Cigna member portal or phone
  • Timeline: Decision within 30-60 days
  • Reviewer: Physician not involved in original denial

External Review (If Internal Appeal Fails)

  • Deadline: 4 months after final internal denial
  • Process: Request through Florida Department of Financial Services
  • Timeline: 45-60 days (72 hours for urgent cases)
  • Reviewer: Independent medical expert
  • Cost: Free to consumer
  • Outcome: Binding on Cigna if overturned

Expedited Reviews: Available for urgent post-exposure situations where delays could compromise effectiveness.

Common Denial Reasons and Solutions

Denial Reason Solution Strategy
"Outside timing window" Submit documentation showing exposure was recent; cite CDC 7-day window
"Not medically necessary" Provide exposure incident report and source patient HBsAg status
"Vaccination preferred" Explain timing urgency; HBIG provides immediate passive immunity
"Quantity excessive" Submit weight-based dosing calculation per FDA label
"Non-formulary" Request formulary exception with medical necessity documentation

Getting Help with Your Appeal

When insurance denials feel overwhelming, specialized support can make a significant difference. Counterforce Health helps patients and clinicians turn insurance denials into successful appeals by analyzing denial letters, identifying the specific basis for rejection, and crafting evidence-backed rebuttals that address insurers' own coverage criteria. Their platform streamlines the appeals process by pulling relevant medical literature, FDA guidance, and payer-specific requirements to build stronger cases for medications like HyperHEP.

FAQ: HyperHEP Coverage in Florida

Q: How long does Cigna prior authorization take for HyperHEP? A: Standard PA decisions are issued within 72 hours for urgent requests, up to 15 days for routine requests. Emergency situations may receive immediate approval.

Q: What if my exposure was more than 7 days ago? A: While CDC guidelines suggest reduced effectiveness after 7 days, some experts support treatment up to 2 weeks post-exposure. Your provider should document the rationale for delayed treatment.

Q: Can I get HyperHEP at an urgent care center? A: Most urgent care centers don't stock HyperHEP. Hospital emergency departments are more likely to have immediate access.

Q: Does Cigna cover HyperHEP for household contacts? A: Yes, if the household contact is HBsAg-positive and the patient lacks immunity. Documentation of the relationship and exposure risk is required.

Q: What if I need multiple doses for transplant prophylaxis? A: Cigna covers transplant protocols but requires detailed dosing schedules, anti-HBs monitoring plans, and regular reassessment of medical necessity.

Q: How much will HyperHEP cost with Cigna coverage? A: Costs vary by plan, but specialty tier copays typically range from $50-200. Check your specific benefits or contact Cigna member services.

From our advocates: We've seen cases where initial HyperHEP denials were overturned simply by resubmitting with clearer exposure timeline documentation and explicit CDC guideline references. The key is often in the details—making sure the medical necessity letter addresses Cigna's specific coverage criteria rather than just general clinical rationale.

For additional support navigating complex prior authorizations, Counterforce Health provides tools and guidance to help strengthen your appeal with targeted, evidence-based documentation that speaks directly to your insurer's requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your specific Cigna plan and consult healthcare providers for medical decisions. For assistance with insurance matters in Florida, contact the Division of Consumer Services at 1-877-693-5236.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.